Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA

Atherosclerosis

Volumn 211, Issue 2, 2010, Pages 676-681

  Cífková, Renata ^a   Škodová, Zdenka ^a   Bruthans, Jan ^a   Adámková, Věra ^a   Jozífová, Marie ^a   Galovcová, Markéta ^a   Wohlfahrt, Peter ^a   Krajčoviechová, Alena ^a   Poledne, Rudolf ^a   Stávek, Petr ^a   Lánská, Věra ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Blood pressure; BMI; Cardiovascular mortality; Hypertension; Lipids; Obesity; Smoking

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; LIPID;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CZECH REPUBLIC; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; CZECH REPUBLIC; FEMALE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; SEX FACTORS;

EID: 77955277014     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.04.007     Document Type: Article

References (22)

1. European cardiovascular disease statistics 2008 2008, European Heart Network, Brussels. 3rd ed.
2. Sans S., Kesteloot H., Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997, 18:1231-1248.
3. Müller-Nordhorn J., Rossnagel K., Mey W., Willich S.N. Regional variation and time trends in mortality from ischaemic heart disease: East and West Germany 10 years after reunification. J Epidemiol Community Health 2004, 58:481-485.
4. Czech health statistics yearbook 2008 2009, Health Information and Statistics Institute of the Czech Republic, Prague.
5. Tunstall-Pedoe H., Kuulasmaa K., Mähönen M., et al. For the WHO MONICA (MONItoring trends and determinants in CArdiovascular disease) Project. Lancet 1999, 353:1547-1557.
6. Graham I., Atar D., Borch-Jonsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007, 14(Suppl. 2):S1-S88.
7. Food consumption data released the Czech Statistical Office at:: Table 03.02: Food consumption and non-alcoholic beverages in 1989-2007. http://www.czso.cz/.
8. Berghofer A., Pischon T., Reinhold T., et al. Obesity prevalence from a European perspective: a systematic review. BMC Public Health 2008, 8:200. 10.1186/1471-2458-8-200.
9. Kuulasmaa K., Tunstall-Pedoe H., Dobson A., et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000, 355:675-687.
10. Seidell J.C. Time trends in obesity: an epidemiological perspective. Horm Metab Res 1997, 29:155-158.
11. Seidell J.C. Obesity in Europe: scaling an epidemic. Int J Obes 1995, 19:S1-S4.
12. Flegal K.M., Caroll M.D., Kuczmarski R.J., Johnson C.L. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes 1998, 22:39-47.
13. Williamson D.F., Madans J., Anda R.F., et al. Smoking cessation and severity of weight gain in a national cohort. N Engl J Med 1991, 324:739-745.
14. Boyle C.A., Dobson A.J., Egger C., Magnus P. Can the increasing weight of Australians be explained by the decreasing prevalence of cigarette smoking?. Int J Obes 1994, 18:55-60.
15. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:e21-e181.
16. Peto R, Lopez AD, Boreham J, Thun M. Mortality from smoking, in developed countries 1950-2000. 2nd ed. Oxford: Oxford University Press; 2006.
17. Lawes C.M.M., Hoorn S.V., Rodgers A. For the International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008, 371:1513-1518.
18. Ascherio A., Hennekens C., Willett W.C., et al. Prospective study on nutritional factors, blood pressure, and hypertension among US women. Hypertension 1996, 27:1065-1072.
19. He F.J., MacGregor G.A. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2009, 23:363-384.
20. Cutler J.A., Sorlie P.D., Wolz M., et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008, 52:818-827.
21. Erdine S., Aran S.N. Current status of hypertension control around the world. Clin Exp Hypertens 2004, 26:731-738.
22. Baigent C., Keech A., Kearney P.M., et al. Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005, 366:1267-1278.